FDA opened for 5 new endpoints in Nov 2020 (vs. only 1 until then) following thorough work by FDA’s Inter-center Wound Healing Work group and industry Wound Experts/FDA Clinical Endpoints Project.
Financing innovations in pharmaceutical development – facilitating the next stage of growth
High level operational report summarising key milestones Q2 2020 and forward looking statement.
Ilya Pharma awarded Euros 5.3 million from EIC Accelerator to fast track Phase II study of first-in-class ILPI100 advanced therapy for wound treatment in people with diabetes
4000 applicants, 72 SMEs awarded, Ilya Pharmas project among the 1.8 % winners!